Director Melvin L. Keating of Agilysys INC (NASDAQ:AGYS) disclosed a series of insider purchases in a Form 4 filed with the Securities and Exchange Commission. The filing shows Keating acquired 390 shares of Agilysys common stock across transactions executed on March 16 and March 17, 2026, with the total consideration reported at $27,289.
The individual share prices for these transactions ranged from $67.98 to $68.49. Following the completion of the purchases, Keatings direct holdings in Agilysys rose to 35,407 shares.
These insider purchases occurred while Agilysys shares were trading roughly 6% above the companys 52-week low of $63.71. The stock has experienced a marked decline year-to-date, falling 43% over that period.
According to analysis cited from InvestingPro, Agilysys shares appear to be trading below that platforms Fair Value calculation, indicating the stock is viewed as undervalued on that particular assessment. The InvestingPro analysis and screening tools are referenced as means investors might use to identify similarly undervalued equities.
Agilysys also released its Q3 2026 financial results prior to the filing. The company reported record quarterly revenue of $80.4 million, exceeding the consensus forecast of $79.07 million. Despite the revenue beat, reported earnings per share were $0.42, below the expected $0.46 and constituting an 8.7% negative surprise versus expectations. The earnings shortfall was noted as a factor in the companys recent stock decline.
Following investor meetings, William Blair reiterated an Outperform rating for Agilysys. Those meetings included participation by CFO Dave Wood and VP of Investor Relations and Operations Jessica Hennessy. A focal point discussed with investors was the Marriott PMS rollout, which management indicated is expected to accelerate over the next year.
The filings and corporate disclosures provide a factual snapshot of recent insider activity, near-term trading context, and the companys latest quarterly results. The record revenue figure and the EPS miss are presented in the companys own reported results, while the insider purchases are documented via the SEC Form 4 filing.
Below are concise takeaways and a short list of risks documented in publicly filed materials and analyst notes referenced above.